Fifth Third Bancorp
ADMA icon

Fifth Third Bancorp’s ADMA Biologics ADMA Stock Holding History

Fifth Third Bancorp’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Sell
49,515
-5,993
-11% -$54.6K ﹤0.01% 2210
2026
Q1 		$500K Buy
55,508
+54,803
+7,773% +$865K ﹤0.01% 2043
2025
Q4 		$12.9K Sell
705
-371
-34% -$6.25K ﹤0.01% 2055
2025
Q3 		$15.8K Sell
1,076
-66
-6% -$1.13K ﹤0.01% 1985
2025
Q2 		$20.8K Buy
1,142
+27
+2% +$551 ﹤0.01% 1764
2025
Q1 		$22.1K Buy
1,115
+672
+152% +$11.6K ﹤0.01% 1722
2024
Q4 		$7.6K Buy
443
+129
+41% +$2.43K ﹤0.01% 2051
2024
Q3 		$6.28K Buy
+314
New +$4.88K ﹤0.01% 2127

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fifth Third Bancorp's ADMA Position: Q2 2026 in Review

Fifth Third Bancorp reduced its ADMA Biologics (ADMA) stake by 11% in Q2 2026, selling an estimated $54.6K and leaving 49,515 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #2210.

Fifth Third Bancorp first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $500K in Q1 2026. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Fifth Third Bancorp held 49,515 shares of ADMA Biologics worth $414K as of Q2 2026.
  • Fifth Third Bancorp sold 5,993 ADMA Biologics shares in Q2 2026, an estimated $54.6K.
  • ADMA Biologics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2210 holding.
  • Fifth Third Bancorp first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Fifth Third Bancorp's ADMA Biologics position peaked at $500K in Q1 2026.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.